Todd M. Heidelbaugh

Person

Fountain Valley, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating α adrenergic mediated conditions
- Patent number 9,849,113
- Issue date Dec 26, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating α adrenergic mediated conditions
- Patent number 9,623,006
- Issue date Apr 18, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coumarin compounds as receptor modulators with therapeutic utility
- Patent number 9,572,792
- Issue date Feb 21, 2017
- Allergan, Inc.
- Todd M. Heidelbaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coumarin compounds as receptor modulators with therapeutic utility
- Patent number 9,073,888
- Issue date Jul 7, 2015
- Allergan, Inc.
- Todd M. Heidelbaugh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating alpha adrenergic mediated conditions
- Patent number 9,034,910
- Issue date May 19, 2015
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds as receptor modulators with therapeutic utility
- Patent number 8,828,973
- Issue date Sep 9, 2014
- Allergan, Inc.
- Phong X. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 8,815,923
- Issue date Aug 26, 2014
- Allergan, Inc.
- Santosh C. Sinha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective subtype alpha 2 adrenergic agents and methods for use the...
- Patent number 8,809,379
- Issue date Aug 19, 2014
- Allergan, Inc.
- Todd M. Heidelbaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds as receptor modulators with therapeutic utility
- Patent number 8,741,875
- Issue date Jun 3, 2014
- Allergan, Inc.
- Todd M. Heidelbaugh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype se...
- Patent number 8,735,438
- Issue date May 27, 2014
- Allergan, Inc.
- Santosh C. Sinha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective subtype alpha 2 adrenergic agents and methods for use the...
- Patent number 8,735,399
- Issue date May 27, 2014
- Allergan, Inc.
- Todd M. Heidelbaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds as receptor modulators with therapeutic utility
- Patent number 8,703,745
- Issue date Apr 22, 2014
- Allergan, Inc.
- Todd M. Heidelbaugh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as receptor modulators with therapeutic utility
- Patent number 8,703,746
- Issue date Apr 22, 2014
- Allergan, Inc.
- Todd M. Heidelbaugh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as receptor modulators with therapeutic utility
- Patent number 8,653,062
- Issue date Feb 18, 2014
- Allergan, Inc.
- Phong X. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as receptor modulators with therapeutic utility
- Patent number 8,653,270
- Issue date Feb 18, 2014
- Allergan, Inc.
- Todd M. Heidelbaugh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 8,486,969
- Issue date Jul 16, 2013
- Allergan, Inc.
- Santosh C. Sinha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective subtype alpha 2 adrenergic agents and methods for use the...
- Patent number 8,486,985
- Issue date Jul 16, 2013
- Allergan, Inc.
- Phong X. Nguyen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds as receptor modulators with therapeutic utility
- Patent number 8,440,644
- Issue date May 14, 2013
- Allergan, Inc.
- Phong X. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 8,426,454
- Issue date Apr 23, 2013
- Allergan, Inc.
- Santosh C. Sinha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compounds
- Patent number 8,383,646
- Issue date Feb 26, 2013
- Allergan, Inc.
- Santosh C. Sinha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective subtype alpha 2 adrenergic agents and methods for use the...
- Patent number 8,362,022
- Issue date Jan 29, 2013
- Allergan, Inc.
- Todd M. Heidelbaugh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective alpha 2B/2C agonists
- Patent number 8,329,918
- Issue date Dec 11, 2012
- Allergan Inc.
- Phong X. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Naphthylmethylimidizoles as therapeutic agents
- Patent number 8,258,167
- Issue date Sep 4, 2012
- Allergan, Inc.
- Todd M. Heidelbaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype se...
- Patent number 8,227,499
- Issue date Jul 24, 2012
- Allergan, Inc.
- Santosh C. Sinha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds as...
- Patent number 8,183,414
- Issue date May 22, 2012
- Allergan, Inc.
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thio...
- Patent number 8,178,571
- Issue date May 15, 2012
- Allergan, Inc.
- Todd M. Heidelbaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective sphingosine-1-phosphate receptor antagonists
- Patent number 8,168,795
- Issue date May 1, 2012
- Allergan, Inc.
- Phong X. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
- Patent number 8,124,774
- Issue date Feb 28, 2012
- Allergan, Inc.
- Santosh C. Sinha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinolynylmethylimidizoles as therapeutic agents
- Patent number 8,119,807
- Issue date Feb 21, 2012
- Allergan, Inc.
- Todd M. Heidelbaugh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...
- Patent number 8,071,635
- Issue date Dec 6, 2011
- Allergan, Inc.
- Ken Chow
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20230062049
- Publication date Mar 2, 2023
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20200330428
- Publication date Oct 22, 2020
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20180344692
- Publication date Dec 6, 2018
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20180071260
- Publication date Mar 15, 2018
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20170172982
- Publication date Jun 22, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COUMARIN COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
- Publication number 20150265573
- Publication date Sep 24, 2015
- Allergan, Inc.
- Todd M. Heidelbaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20150224080
- Publication date Aug 13, 2015
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHOSPHONIC ACID COMPOUNDS AS SPHINGOSINE-1-PHOSPHATE RECEPTOR MODUL...
- Publication number 20140256945
- Publication date Sep 11, 2014
- Allergan, Inc.
- Phong X. NGUYEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
- Publication number 20140221317
- Publication date Aug 7, 2014
- Allergan, Inc.
- Phong X. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THE...
- Publication number 20140206701
- Publication date Jul 24, 2014
- Allergan, Inc.
- Janet A. Takeuchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL AROMATIC THIO COMPOUNDS AS RECEPTOR MODULATORS
- Publication number 20140171393
- Publication date Jun 19, 2014
- Allergan, Inc.
- Phong X. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
- Publication number 20140107075
- Publication date Apr 17, 2014
- Allergan, Inc.
- Todd M. HEIDELBAUGH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
- Publication number 20140057876
- Publication date Feb 27, 2014
- Allergan, Inc.
- Todd M. HEIDELBAUGH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20130217739
- Publication date Aug 22, 2013
- Allergan, Inc.
- Santosh C. Sinha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
- Publication number 20130157982
- Publication date Jun 20, 2013
- Allergan, Inc.
- Todd M. Heidelbaugh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
S1P ANTAGONISTS AS ADJUNCT OCULAR HYPOTENSIVES
- Publication number 20130079290
- Publication date Mar 28, 2013
- Allergan, Inc.
- David F. Woodward
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COUMARIN COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
- Publication number 20120328661
- Publication date Dec 27, 2012
- Allergan, Inc.
- Todd M. Heidelbaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED-ARYL-(IMIDAZOLE)-METHYL)-PHENYL COMPOUNDS AS SUBTYPE SE...
- Publication number 20120202865
- Publication date Aug 9, 2012
- Santosh C. Sinha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
UNSUBSTITUTED AND SUBSTITUTED 4-BENZYL-1,3-DIHYDRO-IMIDAZOLE-2-THIO...
- Publication number 20120196911
- Publication date Aug 2, 2012
- Allergan, Inc.
- Todd M. Heidelbaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS
- Publication number 20120190694
- Publication date Jul 26, 2012
- Allergan, Inc.
- Phong X. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20120165380
- Publication date Jun 28, 2012
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
- Publication number 20120129813
- Publication date May 24, 2012
- Todd M. Heidelbaugh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20120035235
- Publication date Feb 9, 2012
- Allergan, Inc.
- Wenkui K. Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDINE COMPOUNDS AS SUBTYPE SELECTIVE MODULATORS OF ALPHA2B AND /...
- Publication number 20110306635
- Publication date Dec 15, 2011
- ALLERGAN ,INC
- Phong X. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
- Publication number 20110212925
- Publication date Sep 1, 2011
- Allergan, Inc.
- Phong X. NGUYEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20110178143
- Publication date Jul 21, 2011
- Allergan, Inc.
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20110178144
- Publication date Jul 21, 2011
- Allergan, Inc.
- Santosh C. Sinha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
- Publication number 20110152241
- Publication date Jun 23, 2011
- Allergan, Inc.
- Phong X. NGUYEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THE...
- Publication number 20110136884
- Publication date Jun 9, 2011
- Allergan, Inc.
- Phong X. Nguyen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THE...
- Publication number 20110105526
- Publication date May 5, 2011
- Todd M. Heidelbaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Todd M. Heidelbaugh

Person

Patents Grantslast 30 patents

Methods of treating α adrenergic mediated conditions

Methods of treating α adrenergic mediated conditions

Coumarin compounds as receptor modulators with therapeutic utility

Coumarin compounds as receptor modulators with therapeutic utility

Methods of treating alpha adrenergic mediated conditions

Compounds as receptor modulators with therapeutic utility

Therapeutic compounds

Selective subtype alpha 2 adrenergic agents and methods for use the...

Compounds as receptor modulators with therapeutic utility

Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype se...

Selective subtype alpha 2 adrenergic agents and methods for use the...

Compounds as receptor modulators with therapeutic utility

Compounds as receptor modulators with therapeutic utility

Compounds as receptor modulators with therapeutic utility

Compounds as receptor modulators with therapeutic utility

Therapeutic compounds

Selective subtype alpha 2 adrenergic agents and methods for use the...

Compounds as receptor modulators with therapeutic utility

Therapeutic compounds

Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compounds

Selective subtype alpha 2 adrenergic agents and methods for use the...

Selective alpha 2B/2C agonists

Naphthylmethylimidizoles as therapeutic agents

Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype se...

N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds as...

Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thio...

Selective sphingosine-1-phosphate receptor antagonists

Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds

Quinolynylmethylimidizoles as therapeutic agents

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...

Patents Applicationslast 30 patents

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

COUMARIN COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

PHOSPHONIC ACID COMPOUNDS AS SPHINGOSINE-1-PHOSPHATE RECEPTOR MODUL...

NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY

SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THE...

NOVEL AROMATIC THIO COMPOUNDS AS RECEPTOR MODULATORS

NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY

NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY

THERAPEUTIC COMPOUNDS

NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY

S1P ANTAGONISTS AS ADJUNCT OCULAR HYPOTENSIVES

COUMARIN COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY

SUBSTITUTED-ARYL-(IMIDAZOLE)-METHYL)-PHENYL COMPOUNDS AS SUBTYPE SE...

UNSUBSTITUTED AND SUBSTITUTED 4-BENZYL-1,3-DIHYDRO-IMIDAZOLE-2-THIO...

SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

PYRIDINE COMPOUNDS AS SUBTYPE SELECTIVE MODULATORS OF ALPHA2B AND /...

NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY

THERAPEUTIC COMPOUNDS

THERAPEUTIC COMPOUNDS

NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY

SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THE...

SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THE...